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New CMS Guidance on Medicare Part D Creditable Coverage Notice Offers
Helpful Direction for Prescription Drug Plan Sponsors
By Susan E. Cancelosi, J.D., LL.M.
secancel@central.uh.edu

As part of the continuing onslaught of regulatory guidance from the Centers for Medicare
and Medicaid Services (“CMS”) in advance of the January 1, 2006 introduction of the
new Medicare Part D prescription drug benefit, CMS in late May issued welcome
clarification of the creditable coverage notice requirements for plans that currently
provide prescription drug coverage to Medicare beneficiaries.1 The guidance is
accompanied by model notices that entities (other than Medigap insurers) may use to
satisfy the notice requirements.2 Although some businesses may take issue with various
aspects of the guidance and the model notices, CMS has nonetheless resolved a number
of issues for organizations that sponsor prescription drug plans and are struggling to
restructure their programs in light of Medicare Part D.
The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (the
“MMA”) added the new Part D to Medicare to offer a basic outpatient prescription drug
benefit to Medicare beneficiaries beginning January 1, 2006.3 The MMA provides for an
initial enrollment period for Medicare Part D eligible beneficiaries, beginning November
15, 2005 and ending May 15, 2006.4 To push Medicare beneficiaries to move into the
new Part D, the MMA imposes a late enrollment penalty on any eligible individual who
fails to enroll in Part D unless the individual “maintain[s] continuous creditable
prescription drug coverage during the period of non-enrollment.”5 After the initial
enrollment period ends, an eligible individual is subject to the late enrollment penalty if
he or she has a period of 63 days or longer without enrollment in either Part D or other
creditable coverage, then enrolls in Part D.6 The late enrollment penalty is calculated
based on the number of months during which an eligible individual was neither enrolled
in Part D nor otherwise enrolled in creditable coverage and is at least one percent of the
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monthly base beneficiary Part D premium.7 Not only will the penalty never expire, but
CMS notes that the higher premium (due to the late enrollment penalty) will “actually
increase each year” because the late enrollment penalty is calculated as a percentage of
the base premium, which is expected to increase each year.8
Medicare Part D “creditable coverage” includes coverage under a Part D prescription
drug plan, a Medicare Advantage (formerly Medicare+Choice) prescription drug plan, an
employer group health plan (including a retiree prescription drug plan), certain military
and veterans’ prescription drug programs, coverage under Medigap policies, and
coverage under state pharmaceutical assistance plans,9 provided that the coverage meets
an actuarial equivalence requirement specified in the MMA.10 The MMA considers
prescription drug coverage as “creditable coverage” only if the value of the coverage is at
least actuarially equal to the value of the standard Part D prescription drug benefit.11
For a Part D eligible individual who otherwise has prescription drug coverage that will
continue after Part D becomes effective, understanding how that coverage compares to
the Part D standard benefit and the various alternatives available under Part D (including
enrollment in a Medicare Advantage plan that includes prescription drug coverage) will
be critical to effective decision-making. If the individual’s existing prescription drug
coverage qualifies as creditable coverage, the individual should still evaluate whether a
Medicare Part D option offers more valuable coverage for that individual (for example,
due to a different drug formulary or different co-pay structure). If the individual’s
existing prescription drug coverage does not qualify as creditable coverage and the
individual fails to switch to Part D coverage during the initial Part D enrollment period,
the individual will be permanently injured financially by the Part D late enrollment fee.
To aid individuals in understanding their options, the MMA mandates disclosure by
entities offering prescription drug coverage (other than Medicare Part D coverage) of
whether or not their coverage qualifies as creditable coverage, as well as information
about the consequences of failing to enroll in Part D for an individual with coverage that
does not qualify as creditable coverage.12 CMS’ May guidance focuses on this disclosure
and provides far more detail than is available in either the MMA or the related
regulations.
In general, the May guidance clarifies that the determination of creditable coverage for
purposes of the required disclosure does not require an attestation by a qualified actuary
(unless the prescription drug plan is an employer or union plan attempting to qualify for
the MMA’s employer plan subsidy).13 The guidance also provides a safe harbor plan
design that qualifies as creditable coverage.14 Finally, the guidance provides details of
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what the disclosure to eligible beneficiaries should contain, both for individuals in plans
that offer creditable coverage and for individuals in plans with coverage that fails to
qualify as creditable, and clarifies acceptable methods of distributing the notices to
eligible individuals.15 As part of the latter piece of guidance, CMS has posted model
notices on its website.16
Industry commentators have already noted various drawbacks to the guidance. For
example, some employers may feel the model notices “raise more questions than they
answer”17 or are “too confusing or misleading to give to their plan participants.”18
Because the CMS requirements for electronic delivery of the disclosure notices (model or
otherwise) differ from – and appear to be more demanding than – the requirements
applicable to other types of employee communications (particularly the Department of
Labor’s requirements for notices under the Employee Retirement Income Security Act),
employers may find it difficult to comply and be forced to mail notices.19 For employers
who have already planned their benefit communications strategies for the year, the
guidance may be perceived as coming late and disrupting communications plans.20
Employers who had already begun drafting disclosure notices based on the regulations
and previous guidance may find that they must revise those drafts to reflect the details
required by CMS, even if they choose not to adopt the model notices.
On the other hand, for organizations – particularly employers who sponsor retiree
prescription drug plans – that have been waiting to design their communications to plan
participants, the CMS guidance cannot help but be useful. At the very least, it settles any
questions as to what will satisfy CMS and lays to rest concerns that an expensive
actuarial attestation is required even if a plan sponsor does not plan to pursue the MMA’s
employer subsidy. As the months wane until Medicare Part D goes into effect, every bit
of assistance from CMS that clarifies previously unresolved issues should be perceived as
fundamentally useful.

15

Id.
CMS, Model Notices, supra note 2.
17
McDermott Will & Emery, Group Health Plan Sponsors Required to Send New Medicare Notice (June
17, 2005), at http://mwe.com//fuseaction/publications.nldetail_print [hereinafter Comments].
18
Aon Consulting, Alert: Medicare Part D “Creditable Coverage” Model Notices Released (May 31,
2005), at http://www.aon.com/about/publications/pdf/alert/alert_05_31_05.pdf.
19
McDermott, Comments, supra note 17. See also Hewitt Associates, Medicare Part D Creditable
Coverage Guidance Issued by CMS (June 2005), at http://was4.hewitt.com/hewitt/resource/legislative_
updates/united_states/pdfs/creditable_coverage_guidance.pdf.
20
McDermott, Comments, supra note 17.
16

3

